Defense contractor Lockheed Martin has secured the largest missile contract in its corporate history—a nearly $10 billion award from the Pentagon for Patriot missile systems. While such a landmark deal would typically trigger investor enthusiasm, the company’s shares have continued to show lackluster performance, raising questions about the underlying challenges facing the stock.
A Surge in Contract Awards
On September 3, Lockheed Martin announced two major defense contracts. The primary award, valued at $9.8 billion, covers the production of 1,970 PAC-3 MSE interceptors. A separate contract for Javelin missiles, worth $900.5 million, was also secured. Combined, these agreements bring the total value of orders announced in a single day to $10.7 billion, a figure equivalent to approximately 15% of the company’s annual revenue.
The proven effectiveness of the PAC-3 missile system in active combat scenarios has been a key driver of international demand. Jason Reynolds, Vice President of Integrated Air and Missile Defense, noted, “The recent combat performance of the PAC-3 MSE has established it as an indispensable capability for America and its allies across the globe.”
Should investors sell immediately? Or is it worth buying Lockheed?
Strategic Production Ramp-Up Proves Advantageous
A strategic move made nearly two years ago is now paying significant dividends for Lockheed Martin. The company proactively began expanding its production capacity long before the official contract was awarded. This foresight positions the defense giant to deliver more than 600 interceptors in 2025 alone, enabling a swift response to the surge in global demand.
The Investor Enigma
Despite these substantial contract wins, Lockheed Martin’s equity has struggled to gain traction. Since the start of the year, the stock has declined by roughly 6%. This paradox is largely attributed to a difficult second quarter, where the company was burdened by $1.6 billion in program losses and significant write-downs, which severely impacted its profit metrics.
The critical question for investors is whether these new multi-billion dollar awards can reverse the stock’s fortunes. The answer will likely come when Lockheed Martin releases its third-quarter results, expected by the end of October. This earnings report will include an updated financial forecast that incorporates the impact of these recent major contracts.
Ad
Lockheed Stock: Buy or Sell?! New Lockheed Analysis from November 9 delivers the answer:
The latest Lockheed figures speak for themselves: Urgent action needed for Lockheed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 9.
Lockheed: Buy or sell? Read more here...
